The Department of Psychiatry and Behavioral Neurobiology

GRAND ROUNDS

 

PSYCHIATRY HOME

Archived Grand Rounds Schedules
If you need to reference past schedules or presentations, the following schedules are archived for your convenience.  
 2001-2002    2002-2003   2003-2004  2004-2005

2005/2006 GRAND ROUNDS
"The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Alabama School of Medicine designates this educational activity for a maximum of one category 1 credit(s) toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity."


September 2005
October 2005
November 2005 

December 2005 
January 2006
February 2006

March 2006
April 2006
May 2006

 

 September 2005

9/6/05
11:00am
Auditorium
2nd Floor
CPM

 No Grand Rounds Scheduled

9/13/05
11:00am
Auditorium
2nd Floor
CPM
No Grand Rounds Scheduled

9/20/05
11:00am

Auditorium
2nd Floor
CPM

No Grand Rounds Scheduled

9/27/05 Auditorium
2nd Floor
CPM

No Grand Rounds Scheduled

October 2005

10/4/05
11:00am
Auditorium
2nd Floor
CPM
Narrative Medicine on the Medical Ward:  Stories from Patient Care
Fred L. Griffin, M.D.
Associate Professor
Department of Psychiatry and Behavioral Neurobiology
R. Waid Shelton, M.D.
Assistant Professor
Department of Internal Medicine
University of Alabama School of Medicine

 In this presentation the presenters will review the core elements of narrative medical practice and describe their experience introducing narrative medicine to both seasoned medical practitioners and medical students and to house staff on the medical ward.  Examples of narrative writing about the patient’s story of illness and of the physician’s encounters with patients will be provided.  The presenters experience demonstrates that narrative approaches lead to both an enhanced experience for the patient and to greater satisfaction in medical practice for the physician by improving the physician-patient connection.

Objectives:   
1.  Describe core principles of narrative medical practice.
2.  Demonstrate diagnostic and therapeutic benefits of narrative listening in a 
     medical setting.
3.  Describe how the practice of narrative medicine may improve satisfaction for both
     patient and physician by strengthening the physician-patient relationship.
4.  Review the presenter’s experience with narrative discussions (“narrative moments”)
     with both seasoned clinicians in office practice and with medical students and house staff
     on the medical ward.
5.  Describe how narrative medical practice may be initiated on both psychiatric and medical     
    inpatient settings.

References:  
-Charon, R. (2001).  Narrative Medicine: Form Function, and Ethics.  Annals of Internal Medicine,         134:83-87. 

-Griffin , F. (2004). The Fortunate Physician: Learning from Our Patients.  Literature and Medicine. 23:280-303.     http://muse.jhu.edu/journals/literature_and_medicine/v023/23.2griffin.html 
-Horowitz, C. et al (2003).  What Do Doctors Find Meaningful about Their Work?   Annuals of Internal Medicine.  138:772-776.
-UAB SYNOPSIS, June 20, 2005 .  Narrative Medicine.        http://www.health.uab.edu/4docs/show.asp?durki=80929&site=46&return=80927

10/11/05
11:00am
Auditorium
2nd Floor
CPM
Antipsychotic Drugs:  from lab to practice
Daniel R. Weinberger, M.D.
Director, Genes, Cognition and Psychosis Program
National Institute of Mental Health, IRP
National Institute of Mental Health

This talk will review recent data about the pharmacology of antipsychotic drugs based on imaging data and on studies of clinical effects.  The evidence is increasingly focusing on the cortex as the principle site of action of these agents.

Objectives:   
To review recent evidence that the mechanisms of action of antipsychotic drugs are not about DA blockade in the striatum, but involve tuning the cortical processing of information.

We gratefully acknowledge an educational grant  from DIMEDIX / Bristol Myers Squibb Company / Otsuka American Pharmaceutical, Inc. to support this presentation.

 

10/18/05
11:00am

Auditorium
2nd Floor
CPM

NOTE that UAB will not be the CME provider for this presentation.   
The France Foundation, a Continuing Medical Education (CME) company, is implementing all components of this initiative and is the accredited provider of CME credits for the MEASURE program.  Therefore, the certificates will be issued by the France Foundation rather than the UASOM CME office or The Department of Psychiatry.  AstraZeneca Pharmaceuticals is supporting this program by providing an educational grant to the France Foundation.
  ADDITIONAL CME INFORMATION

Evolving Evidence in Bipolar Disorder:  Focus on Depression
Theo C. Manschreck, MD, MPH, AM, MA

Professor of Psychiatry, Harvard Medical School
Boston, Massachusetts
Medical and Research Director,
The John C. Corrigan Mental Health Center
Fall River, Massachusetts

Objectives:   
After participating in this activity, you will be able to
1.  Analyze and interpret the latest clinical data, and through this analysis and interpretation identify diagnostic strategies and treatment goals for your patients with bipolar disorder and other psychiatric disorders
2.  Apply diagnostic strategies learned to recognize and properly identify patients in your practice within the bipolar disorders and other psychiatric disorders
3.  Select and utilize optimal treatment goals for your patients with bipolar disorder or other psychiatric disorders
4.  Use knowledge gained to successfully evaluate and monitor the therapeutic responses of your patients with bipolar and other psychiatric disorders, improving your patient care


References:  Link to Power Point Presentation 

This educational activity is sponsored by The France Foundation and is supported by an educational grant from AstraZeneca.    

10/25/05 Auditorium
2nd Floor
CPM
NO GRAND ROUNDS SCHEDULED


November 2005

11/1/05
11:00am
Auditorium
2nd Floor
CPM
NO GRAND ROUNDS SCHEDULED


11/8/05
11:00am
Auditorium
2nd Floor
CPM
"Epigenetics:  It Runs in the Family"
Robert F. Ackermann, Ph.D.

Associate Professor
Department of Psychiatry and Behavioral Neurobiology
University of Alabama School of Medicine

Nowadays the term "heritability" is often presumed to mean narrowly "gene-determined heritability".  But recently it has become increasingly evident that control of differential gene expression early in development can have important behavioral consequences later in life, and even into the following generation.  We will review some studies that lead to such conclusions.

Objectives:   1) To acquaint the audience with some biological mechanisms that produce variability in gene expression.  2)  To inform the audience how such mechanisms support the diathesis/stress notion of psychopathology, and how they can subserve trans-generational extra-genetic heritability of behavioral characteristics.


References:  Dr. Ackermann will provide a copy of the bibliography for this talk at the rear table in the auditorium.  He will subsequently provide individual copies for anyone who signs up for one.

 

11/15/05
11:00am
Auditorium
2nd Floor
CPM
NO GRAND ROUNDS TODAY 
auditorium unavailable

 

11/22/05
11:00am
Auditorium
2nd Floor
CPM
NO GRAND ROUNDS SCHEDULED
THANKSGIVING HOLIDAY
11/29/05
11:00am
Auditorium
2nd Floor
CPM
Personality as the Product of Emerging Complex Adaptive System
Irving Lazar, Ph.D.

Professor Emeritus,
Human Service Studies, Cornell University  
External Faculty, The Santa Fe Institute

An introduction to complexity theory and its relevance for understanding the emergence of adaptive skills.

Objectives:   
To introduce medical professionals to the sciences of complexity


References:  None provided at this time

 

December 2005 

12/6/05
11:00am
Auditorium
2nd Floor
CPM
Mood Disorders:  A Clinical Research Update
Xiaohua Li, M.D., Assistant Professor
Daniel Dahl, M.D. , Assistant Professor
Charlie Swanson, Jr., M.D., Assistant Professor
Roberta May, M.A., Assistant Professor
Department of Psychiatry and Behavioral Neurobiology
University of Alabama School of Medicine

Objectives:   1) Review the definition and aims of translational research on neuropsychiatric disorders.
2) Summarize progress in translational research with glycogen synthase kinase-3 as a potential therapeutic target in mood disorders.
3) Provide an update on treatment of bipolar disorder using ongoing research projects as a reference.
4) Present information about how symptom-targeted treatment of major depressive disorder may promote remission.


References:  Power Point presentation handout is available.

 

12/13/05
11:00am
Auditorium
2nd Floor
CPM

No Grand Rounds Scheduled

 

12/20/05
11:00am
Auditorium
2nd Floor
CPM

NO GRAND ROUNDS SCHEDULED
HAPPY HOLIDAYS!

12/27/05
11:00am
Auditorium
2nd Floor
CPM
NO GRAND ROUNDS SCHEDULED
HAPPY HOLIDAYS!

PSYCHIATRY HOME

2005/2006 GRAND ROUNDS
"The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity."

January 2006     February 2006     March 2006     April 2006      May 2006

 

January 2006

1/3/06
11:00am
Auditorium
2nd Floor
CPM
NO GRAND ROUNDS SCHEDULED.
HAPPY HOLIDAYS!
1/10/06
11:00am
Auditorium
2nd Floor
CPM
No Grand Rounds scheduled at this time

Objectives:   


References:  

1/17/06
11:00am
Auditorium
2nd Floor
CPM
Curing OCD
James Hooper, M.D., D.F.A.P.A .  

Medical Director, Taylor Hardin Secure Medical Facility, AL DMHMR 
  
 New neurosurgical techniques have drastically changed our understanding of OCD and its treatment.

Objectives:   Attendees will: 
 1)   be able to diagnosis OCD  
 2)   know what treatments are used in OCD
 3)  understand the advanced technology used to cure this disease

References:  1)  Husted DS &  Shapira NA A Review of the Treatment For Refractory OCD: From Medicine to DBS. CNS Spectrum, 9,11, P 833-847. November, 2004   
 2) 
Nemeroff CB: New directions in the development of antidepressants: the interface of neurobiology and psychiatry. Hum Psychopharmacol. 2002 Jun;17 Suppl 1:S13-6.   
 3)
 Anderson D, Ahmed A. Treatment of patients with intractable obsessive-compulsive disorder with anterior capsular stimulation. Case report. J Neurosurg. 2003 May;98(5):1104-8. 
  
Poster Presentation Link

1/24/06
11:00am
Auditorium
2nd Floor
CPM

Schizophrenia & Psychotic Disorders: A Clinical Research Update
Charlie Swanson, Jr., M.D., Assistant Professor
 
Rodney Go, Ph.D., Professor of Public Health
Robert Savage, Ph.D., Associate Professor
Muktar H. Aliyu, Dr.PH
James T. Cullinan, D.O., Assistant Professor 

Roberta May, M.A., Assistant Professor

Department of Psychiatry and Behavioral Neurobiology
University of Alabama School of Medicine


Objectives:   1. Provide an update on treatment of schizophrenia and psychotic disorders using ongoing research projects as a reference.
2. Review the results of a recently completed clinical trial on switching antipsychotic medication.
3. Provide an update on the PAARTNERS project.
4. Present information about upcoming clinical trials and research projects.


References: 
 

1/31/06
11:00am
Auditorium
2nd Floor
CPM

Eye Movement Desensitization and Reprocessing (EMDR)
Nancy Errebo, Psy.D.
Clinical Psychologist, Private Practice,
Missoula, Montana
Training Facilitator,  EMDR Institute,
Watsonville, California
Facilitator and Training, EMDR Humanitarian Assistance Program (EMDR-HAP),
Hamden, Connecticut
·        HAP provides pro bono or low cost EMDR training to clinicians who work with underserved or           highly traumatized populations
·        Member of training team in India, Bangladesh, Turkey, Indonesia, Russia and many US trainings
·        Team leader and trainer in Sri Lanka following the Tsunami

Objectives:   


References:  

 February 2006

2/7/06
11:00am
Auditorium
2nd Floor
CPM

No Grand Rounds Scheduled


Objectives:   


References:


2/14/06
11:00am
Auditorium
2nd Floor
CPM
Accute Assessment of Suicide Threats:  to admit or not to admit?
William Ryan, M.D.
Associate Professor, Public Psychiatry
Department of Psychiatry and Behavioral Neurobiology
University of Alabama School of Medicine

It is common for people to say they are suicidal.  It is rare for people to kill themselves.  Psychiatrists attempt to deal with this paradox and avoid getting sued.

Objectives:   The attendee will become aware of the complexity of evaluating potentially suicidal patients, and begin to develop some skill in putting this awareness in to practice.


References: A reference handout will be available at the presentation.

2/21/06
11:00am

Auditorium
2nd Floor
CPM
CANCELED - Will try to ree-schedule for the 2006-07 Series
George F. Slade, M.D.
Private Practice,  Tallahassee,  Fl
Clinical Professor, College of Medicine at Florida State University and the Family Practice residency program at Tallahassee Memorial Hospital

Objectives:   TBA


References:  TBA

We gratefully acknowledge an educational grant  from  Sanofi-Synthelabo, Inc. to support this presentation.

2/28/06 Auditorium
2nd Floor
CPM
The Targeted Treatment of Depression Controversy:  Current Evidence
Richard J. Metzner, M.D.

Clinical Professor of Psychiatry
Department of Psychiatry and Biobehavioral Sciences, UCLA 

Dr. Metzner will illuminate the pros and cons of TTD using examples of different types of depressed patients from critically acclaimed films and from his own private practice.  The research data presented will include his own computerized comparison of over 1000 depressed outpatients receiving either TTD or non-selective antidepressant medications.

Objectives:   
Those attending will be able to:
1)  Discuss the evidence for and against using different core symptoms of depression to select antidepressants
2)  identify the major depressive subtypes that may prove more responsive to various antidepressant agents
3)  recognize clinical patterns that can signal the need to alter treatment
4)  modify antidepressant regimens in a manner that optimizes the likelihood of recovery

5)  acquire appropriate screening materials to facilitate targeted treatment of depression (TTD)

References:  

We gratefully acknowledge an educational grant  from  GlaxoSmithKline NeuroHealth to support this presentation.

March 2006

3/7/06
11:00am
Auditorium
2nd Floor
CPM

 Impulsivity, suicide, and the structure of bipolar disorder
Alan Craig Swann, M.D.
Pat R. Rutherford, Jr. Professor and Vice Chair for Research
Department of Psychiatry and Behavioral Sciences
University of Texas Medical School at Houston
 

Objectives:  Upon completion of the program, the participant will
1)  Understand how bipolar disorder is related to impulsivity and the initiation of action
2)  Understand how impulsivity is related to complications of bipolar disorder, such as substance abuse and mixed states
3)  Understand how risk for suicide is related to the interaction between impulsivity and hopelessness
4)  Be able to formulate integrated strategies for treatment based on these considerations.

References: 

We gratefully acknowledge an educational grant  from  Abbott Laboratories, Inc. to support this presentation.


3/14/06
11:00am
Auditorium
2nd Floor
CPM
Perfect Health through the Application of Faith and Thought
M. Zahid Husain, M.D. 

Assistant Professor

Department of Psychiatry and Behavioral Neurobiology
University of Alabama School of Medicine

Objectives:   Those attending will be able to: 
1)  Be introduced to a book written in 1910 that showed how to achieve perfect health from an alternative perspective. 
2)  Learn about a few Natural Principles of the Universe, which can be applied to facilitate human well-being. 
3)  Have an understanding of Quantum Physics in achieving desired health outcome.
4)  Learn how to use the sub-conscious mind to manipulate health outcome. 
5)  Be entertained by the creative imaginary mind of a person with bipolar affective disorder.

References:  



3/21/06
11:00am

Auditorium
2nd Floor
CPM
Spring Break - No Grand Rounds Scheduled

3/28/06 Auditorium
2nd Floor
CPM
Post Partum Depression 
Christina Smith, M.D.

PGY-IV Resident in Psychiatry
Department of Psychiatry and Behavioral Neurobiology
University of Alabama School of Medicine

Objectives:   
1)  Discuss the differential diagnosis of post partum mental disorders. 
2) To examine the clinical features of post partum depression and differences between it and other psychiatric illnesses such as Major Depressive Disorder.
3)  To examine the evidence for the etiology of post partum depression, including the contribution of biological, psychological and social factors.
4)  Showcase the evidence for the impact of PPD on the family unit, specifically the children of depressed mothers.
5)  Discuss the possibility of using preventative measures for PPD.
6)  Discuss the importance of early screening and the need for primary care providers to help with screening and diagnosis.

 

 April 2006

4/4/06
11:00am
Auditorium
2nd Floor
CPM
Postpartum Psychosis
Brandi Cooke, M.D.

PGY-IV Resident in Psychiatry
Department of Psychiatry and Behavioral Neurobiology
University of Alabama School of Medicine

Discussion of the clinical, neurobiological and social aspects of postpartum psychosis as Part II of a two part series on postpartum psychiatry.  Emphasize prevention, treatment, and future research directions.  Utilize Andrea Yates case material to illustrate clinical points.
 
Objectives:
  
 
1)  To describe clinical features, diagnosis and risk factors  
2)  To understand proposed neurobiological mechanisms
3)  Discuss treatment options and future directions
4)  To utilize current events case material to illustrate illness
 
4/11/06
11:00am
Auditorium
2nd Floor
CPM

Sleep Deprivation in Residency and Life
John Jeans, M.D.

PGY-IV Resident in Psychiatry
Department of Psychiatry and Behavioral Neurobiology
University of Alabama School of Medicine

Discussion of the effects of sleep deprivation on physiology and its impact on performance and implication for residency training and life consequences.

  
Objectives:
  
To illuminate the potential harm/danger inherent in chronic sleep deprivation.

 

4/18/06
11:00am

Auditorium
2nd Floor
CPM

Role of Psychological Stress and Depression in Heart Disease
Ajmal Khan, M.D.

PGY-IV Resident in Psychiatry
Department of Psychiatry and Behavioral Neurobiology
University of Alabama School of Medicine

 Psychological stress and depression are risk factors for heart disease. 

 
Objectives:
  
To discuss different mechanisms involved and establish stress and depression as risk factors for heart disease.


  

4/25/06 Auditorium
2nd Floor
CPM

Eleventh Residents Versus Faculty Scholar's Bowl  
Moderated by Daniel C. Dahl, M.D.

Assistant Professor, Vice Chairman for Education and Training, Residency Training Director 
Department of Psychiatry and Behavioral Neurobiology
University of Alabama School of Medicine

  
Objectives:
  

References:  

May 2006

5/2/06
11:00am
Auditorium
2nd Floor
CPM
ADHD in Adults
Thad Ryals, M.D.

Private Practice, Birmingham, Alabama
2004 Graduate of the UAB Psychiatry Residency Training Program

The audience will be presented with current biological theory of ADHD as a developmental disorder of executive functioning.  A description of the different aspects of adult ADHD will be illustrated in case histories from speaker's caseload.  Evidence from longitudinal and retrospective studies will be presented as well as genetic and imaging data supporting adult ADHD.  The speaker will demonstrate how current DSM-IV criteria can be modified to identify and diagnose ADHD in adults.

Objectives:   
1)  Understand that ADHD is a life-long developmental disorder
2)  Learn how adult ADHD presents different problems than in children
3)  Learn how modifying current DSM-IV criteria can diagnose ADHD in adults
4)  Lean basic approach to treatment

References:
Attention-Deficit Hyperactivity Disorder, Third Edition: A Handbook for Diagnosis and Treatment by Russell A. Barkley, 2005   ISBN: 159385210X

Attention Deficit Disorder:  The Unfocused Mind in Children and Adults by Thomas E. Brown,  2005  ISBN:  0300106416


5/9/06
11:00am
Auditorium
2nd Floor
CPM

The UAB Borderline Disorder Program: Syndrome, Structure and Outcome
Warren Jackson, Ph.D., Associate Professor
Andrée Stoves, M.D., Assistant Professor - (Discussant)
Department of Psychiatry and Behavioral Neurobiology
University of Alabama School of Medicine

Dialectical Behavior Therapy (DBT) has been an integral part of our program for almost four years.  After a brief overview of Borderline Personality Disorder (BPD), this presentation will provide an overview of our use of DBT with attention to advances in assessment of treatment outcome.

Objectives:   
1) Conceptualize BPD as a disorder of emotional dysregulation. 
2)  Understand the structure of the program and how to access it. 
3)  Understand how the four elements of DBT address the four major problem areas in BPD. 
4)  Learn about the development and use of the UAB Borderline Rating Scale and the Treatment Utilization Form.
We gratefully acknowledge a grant from Janssen to support development of the UAB Borderline Rating Scale.

References: 
American Psychiatric Association practice guidelines for treatment of patients with borderline personality disorder. Am J Psy 2001; 158 (Oct suppl): 1-52. 

Linehan, MM: Skills training manual for treating borderline personality disorder. New York, Guilford, 1993.
 

5/16/06
11:00am

Auditorium
2nd Floor
CPM
Sleep in Neurodegenerative Disease
Donald Linn Bliwise, Ph.D.
Professor, Department of Neurology
Professor
Director, Clinical Core, Alzheimer's Disease Research Center
Director
, Program in Sleep, Aging and Chronobiology

Emory University Medical Center

This presentation will discuss disorders of sleep both as consequences of and causes for neurodegenerative disease.  References will be made to human polysomnographic and chronobiologic studies, as well as selective reference to basic science studies.

Objectives:   
1)  To review current current knowledge regarding neurobiologic substrates for sleep dysfunction in the alpha synucleinopathies. 
2)  To describe pathophysiology involving the circadian timing system in the amyloidopathies. 
3)  To introduce specific sleep disorders as risk factors for, rather than causes of, neurodegeneration.


References:  Handout of Powerpoint presentation will be provided

We gratefully acknowledge an educational grant  from  Takeda Pharmaceuticals to support this presentation.


5/23/06 Auditorium
2nd Floor
CPM
NO GRAND ROUNDS SCHEDULED
American Psychiatric Association Annual Meeting (APA)
May 20 - 25, 2006 
Toronto, Canada
5/30/06 Auditorium
2nd Floor
CPM
C.J. Rosecrans Memorial Lecture
Clinical Neuropsychology in the Era of Cognitive Neuroscience and Neuroimaging
Erin D. Bigler,  Ph.D.

Professor,  Departments of Psychology and Neuroscience
Brigham Young University

Erin D. Bigler, former Chair of the Brigham Young University Psychology Department, is currently a Professor of Psychology and Neuroscience at BYU and an Adjunct Professor of Psychiatry and Radiology for the University of Utah. From 1977 to 1990 he was a Professor of Psychology and Psychiatry at the University of Texas and upon returning to Utah he established the Brain Imaging and Behavior Laboratory at BYU, researching neuroimaging variables in cognitive and neurobehavioral disorders. He is an ABBP Diplomate in clinical neuropsychology, has authored or co-authored 10 textbooks and published over 250 peer-reviewed articles in neuropsychology, neuroimaging and neuroscience.  Currently, he serves as Treasurer for the International Neuropsychological Society (INS) and was a founding Associate Editor of its journal, the Journal of International Neuropsychological Society (JINS).

It was just approximately 30 years ago that computerized tomography was introduced, where for the first time an in vivo image of the brain could be obtained. Within that short time span neuroimaging has progressed from crude images of the brain, to imaging studies that provide exquisite detail of brain anatomy and function. Neuroimaging revolutionized the study of all neuropsychiatric disorders particularly those involving acquired brain injury and has provided detailed anatomical and functional measures to study brain-behavior relationships in the intact and the damaged brain and increasingly of the brain with neurodevelopmental disorders. This lecture will provide a status report of contemporary neuroimaging methods of assessing the acute and chronic effects of acquired brain injury and their relationship to neurocognitive and neurobehavioral outcome as well as a host of other neuropsychiatric disorders. A particular emphasis will be placed on various quantitative methods of assessing structural brain damage using magnetic resonance imaging (MRI) as well as functional imaging methods including functional MRI (fMRI), positron emission tomography (PET), and magnetoencephalography (MEG). Also, the lecture will address neuroimaging and clinical assessment from a life-span perspective.  The lecture will conclude with a discussion of recent neuroimaging findings that relate to the brain reserve hypothesis of recovery of function after injury and the relationship of brain reserve in the injured brain and the development of neurodevelopmental disorders, including dementia later in life.

Objectives:   1)  Provide a status report of contemporary neuroimaging methods of assessing the acute and chronic effects of acquired brain injury and various neurodevelopmental disorders and their relationship to neurocognitive and neurobehavioral outcome.   2)  Address acquired brain injury and various neurodevelopmental disorders from a life-span perspective.  3)  Discuss recent neuroimaging findings in the context of neuropsychiatric disorders.



 

"The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Alabama School of Medicine designates this educational activity for a maximum of 1 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity."

Questions or  comments concerning these activities?  Write, Call, FAX, or E-mail: 

Carol Schaffhausen, Education & Training Program Manager
The University of Alabama at Birmingham
115 Smolian Psychiatric Clinic
1700 Seventh Avenue South
Birmingham, AL 35294-0018 
PHONE 934-1306  FAX 934-4659  cschaff@uabmc.edu

PSYCHIATRY HOME